Hydrophilic Contact Lenses — NCD 233 | CMS Coverage Update

CMS modified NCD 233 for hydrophilic contact lenses, effective January 9, 2026. Here's what billing teams need to know.

The Centers for Medicare & Medicaid Services updated its coverage policy under NCD 233, clarifying when hydrophilic contact lenses qualify for reimbursement under the prosthetic device benefit. This policy draws a hard line: hydrophilic contact lens billing is covered for aphakic patients only. Non-diseased eyes with refractive conditions get nothing. The policy does not list specific CPT or HCPCS codes.

Quick-Reference Table

CMS Hydrophilic Contact Lens Coverage Criteria and Medical Necessity Requirements 2026

NCD 233 is the National Coverage Determination governing Medicare coverage of hydrophilic contact lenses. The rule here is not subtle. CMS treats hydrophilic contact lenses as eyeglasses under §1862(a)(7) of the Social Security Act. That statute excludes eyeglasses from Medicare coverage. So by default, hydrophilic contact lenses are not covered.

There is one exception, and it matters enormously for your revenue. CMS coverage policy allows reimbursement under the prosthetic device benefit when hydrophilic contact lenses are prescribed for an aphakic patient. Aphakia — the absence of the natural crystalline lens, typically following cataract surgery — is the key medical necessity trigger. Without an aphakia diagnosis, the claim will not survive scrutiny.

The CMS hydrophilic contact lens coverage policy also addresses FDA approval. Medicare Administrative Contractors are authorized to accept an FDA letter of approval or other FDA-published material as evidence that a specific lens has received FDA clearance. If you're billing for a newer lens product, confirm FDA approval status before submitting. A MAC can and will use that documentation to validate or reject coverage.

One more coverage path exists: hydrophilic lenses used as corneal bandages. NCD 233 cross-references §80.1 for that specific use case. That's a separate coverage determination. If your practice bills for bandage contact lenses, review §80.1 directly — it operates under different rules than the aphakic coverage here.

There is no prior authorization requirement specified in NCD 233 itself. That doesn't mean your MAC won't require one. Check your regional MAC's local coverage determination before assuming prior authorization isn't needed for high-cost lens products.

CMS Hydrophilic Contact Lens Exclusions and Non-Covered Indications

This is where most claim denial risk lives. CMS is explicit: hydrophilic contact lenses are not covered when used to treat non-diseased eyes. Three specific conditions fall in this bucket.

Spherical ametrophia — a refractive error where the eye doesn't bend light correctly — is excluded. Refractive astigmatism is excluded. Corneal astigmatism is excluded. All three are conditions where contact lenses are commonly prescribed outside Medicare, but Medicare will not pay.

The real issue here is that these are extremely common diagnoses. A lot of patients who wear contact lenses regularly have one or more of these conditions. Your billing team needs to verify the diagnosis before submission, not after a claim denial comes back. Don't assume that because a physician prescribed the lenses, the diagnosis qualifies under NCD 233.

The statutory basis matters too. CMS isn't treating this as a plan-level exclusion — it's embedded in federal law under §1862(a)(7). That means there's no appeals pathway that gets around the exclusion. If the patient has a non-covered diagnosis, the lens is not covered. Full stop.

Coverage Indications at a Glance

CMS Hydrophilic Contact Lens Billing Guidelines and Action Items 2026

1. Audit your diagnosis codes for all pending hydrophilic contact lens claims before submitting.
The effective date of January 9, 2026 means this policy is already active. Any claim you submit now needs to reflect aphakia as the qualifying diagnosis. Pull your queue and check it now.

2. Confirm the aphakia documentation is in the chart.
Medical necessity for the prosthetic device benefit requires a physician prescription for an aphakic patient. "Aphakic patient" needs to be documented explicitly. A vague note about contact lens need won't hold up to a MAC audit. The chart should show the diagnosis, the surgical or clinical history supporting it, and the prescription.

3. Get FDA approval documentation for any lens product you're billing.
NCD 233 explicitly authorizes MACs to require an FDA letter of approval or FDA-published material as evidence. Build this into your intake workflow. If the lens isn't FDA-approved, the claim is not payable regardless of the patient's diagnosis.

4. Separate your bandage lens billing from your aphakic lens billing.
If your practice bills for both hydrophilic lenses for aphakic patients and hydrophilic lenses as corneal bandages, these are governed by different sections. Bandage lenses fall under §80.1. Make sure your charge capture routes each use case to the right coverage bucket. Mixing them up creates unnecessary claim denial exposure.

5. Check your MAC's local coverage determination for prior authorization requirements.
NCD 233 doesn't mandate prior authorization, but your MAC might. Contact lens billing guidelines vary by region. Check before the effective date's claims pile up. If your MAC requires prior auth for prosthetic device claims above a certain dollar threshold, hydrophilic lenses for aphakic patients may qualify.

6. Train your front-end staff on the non-covered indications.
Spherical ametrophia, refractive astigmatism, and corneal astigmatism are common enough that a patient may present with one of these and expect Medicare to cover their lenses. Set expectations at intake. If you collect nothing up front and the claim denies, collecting from the patient after the fact is harder. Use an ABN (Advance Beneficiary Notice of Noncoverage) when there's any doubt about whether the diagnosis qualifies.

7. If your practice has a high volume of mixed-diagnosis contact lens patients, loop in your compliance officer.
The line between covered and non-covered is clear in the policy but may get blurry in documentation from referring providers. If you're not sure how a specific patient's chart maps to NCD 233, talk to your compliance officer before submitting. A post-payment audit on a batch of misclassified lens claims is expensive and avoidable.

CPT, HCPCS, and ICD-10 Codes for Hydrophilic Contact Lenses Under NCD 233

A Note on Code Availability

NCD 233 does not list specific CPT or HCPCS codes. This is not unusual for older NCDs, but it creates real work for your billing team. You need to identify the correct codes through your MAC's billing guidelines and the Medicare Benefit Policy Manual cross-references.

The policy cross-references two sections of the Medicare Benefit Policy Manual:

• Chapter 15, "Covered Medical and Other Health Services," §100 and §120 — for prosthetic device billing guidelines
• Chapter 16, "General Exclusions from Coverage," §20 and §90 — for the eyeglass/contact lens exclusion rules

Pull those manual sections and reconcile your charge capture against them. Your MAC may also have published a local coverage determination or billing article that assigns specific HCPCS codes to aphakic contact lens claims. Check the MAC's website directly.

What to Look For

Contact lens HCPCS codes typically fall in the V-code range (vision-related supply codes). For aphakic patients specifically, your MAC billing guidance will direct you to the appropriate V-code. Do not use a standard refractive contact lens code for an aphakic patient — the diagnosis and the code need to align to the prosthetic device benefit, not the vision benefit.

If you're billing for corneal bandage use under §80.1, those codes are separate and may differ from aphakic lens codes. Confirm both with your MAC before the next claim run.